HK1114601A1 - Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions - Google Patents

Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions

Info

Publication number
HK1114601A1
HK1114601A1 HK08104465.0A HK08104465A HK1114601A1 HK 1114601 A1 HK1114601 A1 HK 1114601A1 HK 08104465 A HK08104465 A HK 08104465A HK 1114601 A1 HK1114601 A1 HK 1114601A1
Authority
HK
Hong Kong
Prior art keywords
cyclopentanones
treatment
ocular hypertensive
hypertensive conditions
substituted cyclopentanes
Prior art date
Application number
HK08104465.0A
Other languages
English (en)
Inventor
David W Old
Todd S Gac
Vinh X Ngo
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of HK1114601A1 publication Critical patent/HK1114601A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/74—Unsaturated compounds containing —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C07C69/736—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK08104465.0A 2005-01-14 2008-04-22 Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions HK1114601A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64406905P 2005-01-14 2005-01-14
PCT/US2006/000831 WO2006076370A2 (en) 2005-01-14 2006-01-10 Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions

Publications (1)

Publication Number Publication Date
HK1114601A1 true HK1114601A1 (en) 2008-11-07

Family

ID=36678136

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08104465.0A HK1114601A1 (en) 2005-01-14 2008-04-22 Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions

Country Status (20)

Country Link
US (1) US7635716B2 (xx)
EP (1) EP1846354B1 (xx)
JP (1) JP5060311B2 (xx)
KR (1) KR101227808B1 (xx)
CN (1) CN101102989B (xx)
AR (1) AR052876A1 (xx)
AT (1) ATE465986T1 (xx)
AU (1) AU2006205029B2 (xx)
BR (1) BRPI0605926A2 (xx)
CA (1) CA2593661A1 (xx)
DE (1) DE602006013945D1 (xx)
DK (1) DK1846354T3 (xx)
ES (1) ES2343430T3 (xx)
HK (1) HK1114601A1 (xx)
IL (1) IL184025A (xx)
MX (1) MX2007008188A (xx)
NZ (1) NZ555945A (xx)
TW (1) TWI379696B (xx)
WO (1) WO2006076370A2 (xx)
ZA (1) ZA200704739B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
WO2007005176A1 (en) 2005-06-29 2007-01-11 Allergan, Inc. Pyrrolidinones for the treatment of glaucoma and ocular hypertension
WO2007149829A2 (en) 2006-06-20 2007-12-27 Allergan, Inc. Therapeutic compounds
JP5532302B2 (ja) * 2006-07-10 2014-06-25 アラーガン インコーポレイテッド 治療化合物
US20080015219A1 (en) * 2006-07-11 2008-01-17 Allergan, Inc. Therapeutic compounds
US7507817B2 (en) 2006-11-17 2009-03-24 Allergan, Inc. Prostaglandin prodrugs
BRPI0806716A2 (pt) * 2007-01-22 2011-09-06 Allergan Inc arilciclopentenos substituìdos como agentes terapêuticos
NZ582705A (en) * 2007-07-03 2012-06-29 Allergan Inc Therapeutic substituted cyclopentanes for reducing intraocular pressure
US8158676B2 (en) * 2007-11-29 2012-04-17 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
BRPI0911543A2 (pt) * 2008-04-24 2015-10-13 Allergan Inc arilciclopentenos substituídos como agentes terapêuticos
PL3062775T3 (pl) 2013-10-31 2018-05-30 Allergan, Inc. Implanty wewnątrzgałkowe zawierające prostamid i sposoby ich stosowania
TW201613864A (en) 2014-02-20 2016-04-16 Takeda Pharmaceutical Novel compounds
WO2015175544A1 (en) 2014-05-12 2015-11-19 Allergan, Inc. Quaternary ammonium alkyl esters of prostanoid derivatives as stable prodrugs

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980700A (en) 1971-10-07 1976-09-14 G. D. Searle & Co. Prostaglandin intermediates and optically active isomers thereof
SE436037B (sv) * 1976-04-30 1984-11-05 Roussel Uclaf Sett att framstella nya 11-desoxi-prostaglandin-f?712-derivat
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
ATE390917T1 (de) 1996-12-20 2008-04-15 Pfizer Prävention und behandlung von skeletterkrankungen mit ep2 subtyp selektiven prostaglandin e2 agonisten
AU7349298A (en) 1997-06-23 1999-01-04 Pfizer Inc. Prostaglandin agonists
US6437146B1 (en) 1998-09-25 2002-08-20 Fujisawa Pharmaceutical Co., Ltd. Oxazole compounds as prostaglandin e2 agonists or antagonists
IL139941A0 (en) 1999-12-02 2002-02-10 Pfizer Prod Inc Use of prostaglandin agonists to treat erectile dysfunction or impotence
US6291522B1 (en) * 2000-09-27 2001-09-18 Allergan Sales, Inc. Cyclopentane heptan(ENE)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents
MXPA04004164A (es) 2001-11-05 2004-09-06 Allergan Inc Analogos de omega-cicloalquil 17-heteroaril prostaglandina e2 como agonistas del receptor ep2.
MXPA04008596A (es) 2002-03-05 2004-12-06 Ono Pharmaceutical Co Compuestos derivados de 8-azaprostaglandina y farmacos que contienen los compuestos como ingrediente activo.
JPWO2004089411A1 (ja) 2003-04-03 2006-07-06 小野薬品工業株式会社 脊柱管狭窄症治療剤
US7323591B2 (en) * 2006-01-10 2008-01-29 Allergan, Inc. Substituted cyclopentanes or cyclopentanones as therapeutic agents
WO2007149829A2 (en) * 2006-06-20 2007-12-27 Allergan, Inc. Therapeutic compounds

Also Published As

Publication number Publication date
DK1846354T3 (da) 2010-08-16
BRPI0605926A2 (pt) 2009-05-26
IL184025A0 (en) 2008-12-29
JP2008526970A (ja) 2008-07-24
ES2343430T3 (es) 2010-07-30
WO2006076370A3 (en) 2007-01-11
US7635716B2 (en) 2009-12-22
MX2007008188A (es) 2007-08-07
KR101227808B1 (ko) 2013-01-30
WO2006076370A2 (en) 2006-07-20
CN101102989A (zh) 2008-01-09
ATE465986T1 (de) 2010-05-15
WO2006076370B1 (en) 2007-02-22
JP5060311B2 (ja) 2012-10-31
CA2593661A1 (en) 2006-07-20
EP1846354A2 (en) 2007-10-24
KR20070094919A (ko) 2007-09-27
TWI379696B (en) 2012-12-21
US20080058414A1 (en) 2008-03-06
TW200714312A (en) 2007-04-16
AU2006205029B2 (en) 2012-09-06
AU2006205029A1 (en) 2006-07-20
ZA200704739B (en) 2009-10-28
DE602006013945D1 (de) 2010-06-10
EP1846354B1 (en) 2010-04-28
AR052876A1 (es) 2007-04-11
NZ555945A (en) 2011-01-28
IL184025A (en) 2012-09-24
CN101102989B (zh) 2011-11-16

Similar Documents

Publication Publication Date Title
IL184025A0 (en) Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
HK1131141A1 (en) Imidazolothiazole compounds for the treatment of disease
IL191283A (en) Compositions for treating eye irregularities
PL2035358T3 (pl) Sposób wytwarzania 1,2-dichloroetanu
EG25812A (en) Process for the manufacture of 1,2-dichloroethane
HK1206262A1 (en) Implants for the treatment of dopamine associated states
ZA200706113B (en) Method for the treatment of copper-bearing materials
IL188728A0 (en) Methods of treating epileptogenesis
ZA200708033B (en) Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
GB0515035D0 (en) Treatment of atherosclerotic conditions
EP1865952A4 (en) COMPOSITIONS CONTAINING HISTAMINES FOR THE TREATMENT OF ALLERGIES
GB0602857D0 (en) The treatment of sialorrhoea
PL380473A1 (pl) Sposób wytwarzania modyfikowanego kaolinu
GB0601091D0 (en) The Treatment Of Ocular Conditions
TJ20050863A (en) The way of narcotism treatment
GB0516753D0 (en) Molecular methods for the treatment of disease
PL383684A1 (pl) Podstawione cyklopentany lub cyklopentanony jako środki terapeutyczne
GB0602858D0 (en) The treatment of sialorrhoea
GB0602855D0 (en) The Treatment Of Sialorrhoea
AU2005905684A0 (en) Compounds for the treatment of irritable bowel syndrome
IL185858A0 (en) Method for the representation of 3,3,4,4-tetrachlorotetrahydrothiophene-1,1-dioxide
PL369391A1 (en) Method for manufacture of disinfectant as well as the disinfectant
AU2005904265A0 (en) Treatment of polymers
GB0518003D0 (en) Treatment of hepatatis c

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150110